nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—S100A4—breast cancer	0.361	0.955	CbGaD
Trifluoperazine—EBPL—Tamoxifen—breast cancer	0.118	0.307	CbGbCtD
Trifluoperazine—EBP—Raloxifene—breast cancer	0.0591	0.153	CbGbCtD
Trifluoperazine—EBP—Tamoxifen—breast cancer	0.0391	0.101	CbGbCtD
Trifluoperazine—UGT1A4—Tamoxifen—breast cancer	0.0355	0.0923	CbGbCtD
Trifluoperazine—Promazine—Tamoxifen—breast cancer	0.0313	1	CrCrCtD
Trifluoperazine—SIGMAR1—Raloxifene—breast cancer	0.0254	0.0659	CbGbCtD
Trifluoperazine—HTR6—Raloxifene—breast cancer	0.019	0.0494	CbGbCtD
Trifluoperazine—ABCB1—breast cancer	0.0171	0.0453	CbGaD
Trifluoperazine—SIGMAR1—Tamoxifen—breast cancer	0.0168	0.0436	CbGbCtD
Trifluoperazine—XDH—Carboplatin—breast cancer	0.015	0.0388	CbGbCtD
Trifluoperazine—XDH—Doxorubicin—breast cancer	0.00856	0.0222	CbGbCtD
Trifluoperazine—CYP1A2—Anastrozole—breast cancer	0.00796	0.0207	CbGbCtD
Trifluoperazine—CYP1A2—Toremifene—breast cancer	0.00728	0.0189	CbGbCtD
Trifluoperazine—ABCB1—Toremifene—breast cancer	0.00637	0.0165	CbGbCtD
Trifluoperazine—ABCB1—Lapatinib—breast cancer	0.00464	0.0121	CbGbCtD
Trifluoperazine—CYP1A2—Tamoxifen—breast cancer	0.00266	0.0069	CbGbCtD
Trifluoperazine—ABCB1—Vinorelbine—breast cancer	0.00258	0.00669	CbGbCtD
Trifluoperazine—ABCB1—Tamoxifen—breast cancer	0.00233	0.00604	CbGbCtD
Trifluoperazine—ABCB1—Mitoxantrone—breast cancer	0.00227	0.00589	CbGbCtD
Trifluoperazine—ABCB1—Gemcitabine—breast cancer	0.002	0.0052	CbGbCtD
Trifluoperazine—CYP1A2—Fluorouracil—breast cancer	0.00196	0.00509	CbGbCtD
Trifluoperazine—ABCB1—Paclitaxel—breast cancer	0.00181	0.0047	CbGbCtD
Trifluoperazine—ABCB1—Irinotecan—breast cancer	0.00179	0.00464	CbGbCtD
Trifluoperazine—ABCB1—Vinblastine—breast cancer	0.00159	0.00412	CbGbCtD
Trifluoperazine—ABCB1—Docetaxel—breast cancer	0.00131	0.0034	CbGbCtD
Trifluoperazine—S100A4—nipple—breast cancer	0.00128	0.0315	CbGeAlD
Trifluoperazine—EBPL—epithelium—breast cancer	0.00109	0.0269	CbGeAlD
Trifluoperazine—S100A4—embryo—breast cancer	0.00105	0.026	CbGeAlD
Trifluoperazine—ABCB1—Doxorubicin—breast cancer	0.000975	0.00253	CbGbCtD
Trifluoperazine—S100A4—Desoximetasone—Fluoxymesterone—breast cancer	0.000959	0.828	CbGdCrCtD
Trifluoperazine—ABCB1—Methotrexate—breast cancer	0.000945	0.00245	CbGbCtD
Trifluoperazine—EBPL—adipose tissue—breast cancer	0.000881	0.0217	CbGeAlD
Trifluoperazine—EBP—uterus—breast cancer	0.000863	0.0213	CbGeAlD
Trifluoperazine—S100A4—epithelium—breast cancer	0.00086	0.0212	CbGeAlD
Trifluoperazine—S100A4—skin of body—breast cancer	0.000818	0.0202	CbGeAlD
Trifluoperazine—CALY—pituitary gland—breast cancer	0.000809	0.02	CbGeAlD
Trifluoperazine—EBPL—adrenal gland—breast cancer	0.00079	0.0195	CbGeAlD
Trifluoperazine—EBP—female reproductive system—breast cancer	0.000776	0.0192	CbGeAlD
Trifluoperazine—S100A4—endometrium—breast cancer	0.000771	0.019	CbGeAlD
Trifluoperazine—EBPL—female gonad—breast cancer	0.000737	0.0182	CbGeAlD
Trifluoperazine—S100A4—uterus—breast cancer	0.000711	0.0175	CbGeAlD
Trifluoperazine—S100A4—pituitary gland—breast cancer	0.000698	0.0172	CbGeAlD
Trifluoperazine—S100A4—adipose tissue—breast cancer	0.000695	0.0172	CbGeAlD
Trifluoperazine—EBPL—endocrine gland—breast cancer	0.000685	0.0169	CbGeAlD
Trifluoperazine—EBP—endocrine gland—breast cancer	0.000657	0.0162	CbGeAlD
Trifluoperazine—TNNC1—endometrium—breast cancer	0.000649	0.016	CbGeAlD
Trifluoperazine—S100A4—female reproductive system—breast cancer	0.000639	0.0158	CbGeAlD
Trifluoperazine—CALY—endocrine gland—breast cancer	0.000626	0.0155	CbGeAlD
Trifluoperazine—S100A4—adrenal gland—breast cancer	0.000624	0.0154	CbGeAlD
Trifluoperazine—S100A4—bone marrow—breast cancer	0.000603	0.0149	CbGeAlD
Trifluoperazine—TNNC1—pituitary gland—breast cancer	0.000588	0.0145	CbGeAlD
Trifluoperazine—TNNC1—adipose tissue—breast cancer	0.000585	0.0144	CbGeAlD
Trifluoperazine—S100A4—female gonad—breast cancer	0.000582	0.0144	CbGeAlD
Trifluoperazine—CALM3—mammary gland—breast cancer	0.000566	0.014	CbGeAlD
Trifluoperazine—S100A4—endocrine gland—breast cancer	0.000541	0.0133	CbGeAlD
Trifluoperazine—TNNC1—adrenal gland—breast cancer	0.000525	0.013	CbGeAlD
Trifluoperazine—SIGMAR1—mammary gland—breast cancer	0.000506	0.0125	CbGeAlD
Trifluoperazine—XDH—endometrium—breast cancer	0.000494	0.0122	CbGeAlD
Trifluoperazine—UGT1A4—endocrine gland—breast cancer	0.000475	0.0117	CbGeAlD
Trifluoperazine—EBPL—lymph node—breast cancer	0.000474	0.0117	CbGeAlD
Trifluoperazine—CALM3—nipple—breast cancer	0.000468	0.0116	CbGeAlD
Trifluoperazine—CALM1—mammary gland—breast cancer	0.000443	0.0109	CbGeAlD
Trifluoperazine—CALY—lymph node—breast cancer	0.000433	0.0107	CbGeAlD
Trifluoperazine—SIGMAR1—nipple—breast cancer	0.000419	0.0103	CbGeAlD
Trifluoperazine—XDH—female reproductive system—breast cancer	0.000409	0.0101	CbGeAlD
Trifluoperazine—S100A4—lymph node—breast cancer	0.000374	0.00923	CbGeAlD
Trifluoperazine—CALM2—nipple—breast cancer	0.000368	0.00908	CbGeAlD
Trifluoperazine—CALM1—nipple—breast cancer	0.000366	0.00904	CbGeAlD
Trifluoperazine—XDH—endocrine gland—breast cancer	0.000346	0.00855	CbGeAlD
Trifluoperazine—TNNC1—lymph node—breast cancer	0.000315	0.00777	CbGeAlD
Trifluoperazine—CALM2—embryo—breast cancer	0.000303	0.00749	CbGeAlD
Trifluoperazine—CALM1—embryo—breast cancer	0.000302	0.00746	CbGeAlD
Trifluoperazine—CYP1A2—nipple—breast cancer	0.000285	0.00704	CbGeAlD
Trifluoperazine—CALM3—endometrium—breast cancer	0.000283	0.00698	CbGeAlD
Trifluoperazine—HRH1—nipple—breast cancer	0.000267	0.00659	CbGeAlD
Trifluoperazine—CALM3—uterus—breast cancer	0.000261	0.00643	CbGeAlD
Trifluoperazine—CALM3—pituitary gland—breast cancer	0.000256	0.00632	CbGeAlD
Trifluoperazine—CALM3—adipose tissue—breast cancer	0.000255	0.00629	CbGeAlD
Trifluoperazine—SIGMAR1—endometrium—breast cancer	0.000253	0.00624	CbGeAlD
Trifluoperazine—CALM2—epithelium—breast cancer	0.000248	0.00611	CbGeAlD
Trifluoperazine—CALM1—epithelium—breast cancer	0.000247	0.00608	CbGeAlD
Trifluoperazine—CALM2—skin of body—breast cancer	0.000236	0.00581	CbGeAlD
Trifluoperazine—CALM1—skin of body—breast cancer	0.000234	0.00579	CbGeAlD
Trifluoperazine—SIGMAR1—uterus—breast cancer	0.000233	0.00575	CbGeAlD
Trifluoperazine—ADRA1A—epithelium—breast cancer	0.000232	0.00573	CbGeAlD
Trifluoperazine—SIGMAR1—pituitary gland—breast cancer	0.000229	0.00565	CbGeAlD
Trifluoperazine—CALM3—adrenal gland—breast cancer	0.000229	0.00564	CbGeAlD
Trifluoperazine—SIGMAR1—adipose tissue—breast cancer	0.000228	0.00562	CbGeAlD
Trifluoperazine—HTR2C—female reproductive system—breast cancer	0.000222	0.00549	CbGeAlD
Trifluoperazine—CALM2—endometrium—breast cancer	0.000222	0.00548	CbGeAlD
Trifluoperazine—CALM3—bone marrow—breast cancer	0.000221	0.00546	CbGeAlD
Trifluoperazine—CALM1—endometrium—breast cancer	0.000221	0.00546	CbGeAlD
Trifluoperazine—CALM3—female gonad—breast cancer	0.000213	0.00526	CbGeAlD
Trifluoperazine—CALM2—uterus—breast cancer	0.000205	0.00505	CbGeAlD
Trifluoperazine—SIGMAR1—adrenal gland—breast cancer	0.000204	0.00504	CbGeAlD
Trifluoperazine—CALM1—uterus—breast cancer	0.000204	0.00503	CbGeAlD
Trifluoperazine—CALM2—pituitary gland—breast cancer	0.000201	0.00496	CbGeAlD
Trifluoperazine—CALM2—adipose tissue—breast cancer	0.0002	0.00494	CbGeAlD
Trifluoperazine—CALM1—pituitary gland—breast cancer	0.0002	0.00494	CbGeAlD
Trifluoperazine—EBP—Azacitidine—Gemcitabine—breast cancer	0.000199	0.172	CbGdCrCtD
Trifluoperazine—CALM1—adipose tissue—breast cancer	0.000199	0.00492	CbGeAlD
Trifluoperazine—SIGMAR1—bone marrow—breast cancer	0.000198	0.00488	CbGeAlD
Trifluoperazine—CHRM2—endocrine gland—breast cancer	0.000195	0.00482	CbGeAlD
Trifluoperazine—Antrafenine—PTGS1—breast cancer	0.000195	0.106	CrCbGaD
Trifluoperazine—SIGMAR1—female gonad—breast cancer	0.000191	0.0047	CbGeAlD
Trifluoperazine—ADRA1A—adipose tissue—breast cancer	0.000188	0.00463	CbGeAlD
Trifluoperazine—DRD2—pituitary gland—breast cancer	0.000185	0.00456	CbGeAlD
Trifluoperazine—HTR2A—embryo—breast cancer	0.000184	0.00454	CbGeAlD
Trifluoperazine—CALM2—female reproductive system—breast cancer	0.000184	0.00454	CbGeAlD
Trifluoperazine—CALM1—female reproductive system—breast cancer	0.000183	0.00452	CbGeAlD
Trifluoperazine—HTR1A—adrenal gland—breast cancer	0.000183	0.00451	CbGeAlD
Trifluoperazine—HRH1—epithelium—breast cancer	0.00018	0.00444	CbGeAlD
Trifluoperazine—CALM2—adrenal gland—breast cancer	0.00018	0.00443	CbGeAlD
Trifluoperazine—CALM1—adrenal gland—breast cancer	0.000179	0.00441	CbGeAlD
Trifluoperazine—CALM2—bone marrow—breast cancer	0.000174	0.00429	CbGeAlD
Trifluoperazine—CALM1—bone marrow—breast cancer	0.000173	0.00427	CbGeAlD
Trifluoperazine—ADRA1A—adrenal gland—breast cancer	0.000168	0.00416	CbGeAlD
Trifluoperazine—CALM2—female gonad—breast cancer	0.000167	0.00413	CbGeAlD
Trifluoperazine—CALM1—female gonad—breast cancer	0.000167	0.00411	CbGeAlD
Trifluoperazine—HRH1—endometrium—breast cancer	0.000161	0.00398	CbGeAlD
Trifluoperazine—HTR1A—endocrine gland—breast cancer	0.000158	0.00391	CbGeAlD
Trifluoperazine—CALM2—endocrine gland—breast cancer	0.000156	0.00384	CbGeAlD
Trifluoperazine—CALM1—endocrine gland—breast cancer	0.000155	0.00383	CbGeAlD
Trifluoperazine—HTR2A—epithelium—breast cancer	0.00015	0.00371	CbGeAlD
Trifluoperazine—ADRA1A—endocrine gland—breast cancer	0.000146	0.0036	CbGeAlD
Trifluoperazine—HRH1—adipose tissue—breast cancer	0.000145	0.00359	CbGeAlD
Trifluoperazine—DRD2—endocrine gland—breast cancer	0.000143	0.00353	CbGeAlD
Trifluoperazine—CALM3—lymph node—breast cancer	0.000137	0.00338	CbGeAlD
Trifluoperazine—HRH1—female reproductive system—breast cancer	0.000134	0.0033	CbGeAlD
Trifluoperazine—HRH1—adrenal gland—breast cancer	0.00013	0.00322	CbGeAlD
Trifluoperazine—SIGMAR1—lymph node—breast cancer	0.000122	0.00302	CbGeAlD
Trifluoperazine—HTR2A—pituitary gland—breast cancer	0.000122	0.00301	CbGeAlD
Trifluoperazine—HRH1—female gonad—breast cancer	0.000122	0.003	CbGeAlD
Trifluoperazine—CYP1A2—endocrine gland—breast cancer	0.000121	0.00298	CbGeAlD
Trifluoperazine—ABCB1—embryo—breast cancer	0.000121	0.00298	CbGeAlD
Trifluoperazine—HRH1—endocrine gland—breast cancer	0.000113	0.00279	CbGeAlD
Trifluoperazine—HTR2A—female reproductive system—breast cancer	0.000112	0.00275	CbGeAlD
Trifluoperazine—Antrafenine—PTGS2—breast cancer	0.000111	0.0604	CrCbGaD
Trifluoperazine—HTR2A—adrenal gland—breast cancer	0.000109	0.00269	CbGeAlD
Trifluoperazine—CALM2—lymph node—breast cancer	0.000108	0.00266	CbGeAlD
Trifluoperazine—CALM1—lymph node—breast cancer	0.000107	0.00264	CbGeAlD
Trifluoperazine—ABCB1—epithelium—breast cancer	9.84e-05	0.00243	CbGeAlD
Trifluoperazine—HTR2A—endocrine gland—breast cancer	9.44e-05	0.00233	CbGeAlD
Trifluoperazine—ABCB1—endometrium—breast cancer	8.82e-05	0.00218	CbGeAlD
Trifluoperazine—Ethopropazine—BCHE—breast cancer	8.51e-05	0.0461	CrCbGaD
Trifluoperazine—ABCB1—uterus—breast cancer	8.13e-05	0.00201	CbGeAlD
Trifluoperazine—ABCB1—pituitary gland—breast cancer	7.99e-05	0.00197	CbGeAlD
Trifluoperazine—ABCB1—adipose tissue—breast cancer	7.95e-05	0.00196	CbGeAlD
Trifluoperazine—HRH1—lymph node—breast cancer	7.81e-05	0.00193	CbGeAlD
Trifluoperazine—ABCB1—female reproductive system—breast cancer	7.31e-05	0.0018	CbGeAlD
Trifluoperazine—Clomipramine—GSTP1—breast cancer	7.14e-05	0.0387	CrCbGaD
Trifluoperazine—ABCB1—adrenal gland—breast cancer	7.13e-05	0.00176	CbGeAlD
Trifluoperazine—Triflupromazine—BCHE—breast cancer	6.97e-05	0.0378	CrCbGaD
Trifluoperazine—ABCB1—bone marrow—breast cancer	6.9e-05	0.0017	CbGeAlD
Trifluoperazine—ABCB1—female gonad—breast cancer	6.65e-05	0.00164	CbGeAlD
Trifluoperazine—ABCB1—endocrine gland—breast cancer	6.19e-05	0.00153	CbGeAlD
Trifluoperazine—Flupentixol—ABCB1—breast cancer	5.01e-05	0.0272	CrCbGaD
Trifluoperazine—Eosinophilia—Methotrexate—breast cancer	4.95e-05	0.000601	CcSEcCtD
Trifluoperazine—Nausea—Vinblastine—breast cancer	4.94e-05	0.000601	CcSEcCtD
Trifluoperazine—Insomnia—Fluorouracil—breast cancer	4.94e-05	0.000601	CcSEcCtD
Trifluoperazine—Somnolence—Gemcitabine—breast cancer	4.94e-05	0.0006	CcSEcCtD
Trifluoperazine—Convulsion—Paclitaxel—breast cancer	4.94e-05	0.0006	CcSEcCtD
Trifluoperazine—Fatigue—Mitoxantrone—breast cancer	4.92e-05	0.000598	CcSEcCtD
Trifluoperazine—Fatigue—Irinotecan—breast cancer	4.92e-05	0.000598	CcSEcCtD
Trifluoperazine—Pruritus—Vinorelbine—breast cancer	4.89e-05	0.000595	CcSEcCtD
Trifluoperazine—Clozapine—CYP1B1—breast cancer	4.88e-05	0.0265	CrCbGaD
Trifluoperazine—Constipation—Irinotecan—breast cancer	4.88e-05	0.000593	CcSEcCtD
Trifluoperazine—Constipation—Mitoxantrone—breast cancer	4.88e-05	0.000593	CcSEcCtD
Trifluoperazine—Dyspnoea—Fluorouracil—breast cancer	4.87e-05	0.000592	CcSEcCtD
Trifluoperazine—Rash—Goserelin—breast cancer	4.87e-05	0.000592	CcSEcCtD
Trifluoperazine—Hypersensitivity—Thiotepa—breast cancer	4.87e-05	0.000591	CcSEcCtD
Trifluoperazine—Dermatitis—Goserelin—breast cancer	4.86e-05	0.000591	CcSEcCtD
Trifluoperazine—Somnolence—Fluorouracil—breast cancer	4.86e-05	0.00059	CcSEcCtD
Trifluoperazine—Headache—Goserelin—breast cancer	4.84e-05	0.000588	CcSEcCtD
Trifluoperazine—Erythema—Docetaxel—breast cancer	4.83e-05	0.000587	CcSEcCtD
Trifluoperazine—Decreased appetite—Gemcitabine—breast cancer	4.83e-05	0.000587	CcSEcCtD
Trifluoperazine—Nausea—Tamoxifen—breast cancer	4.8e-05	0.000584	CcSEcCtD
Trifluoperazine—Fatigue—Gemcitabine—breast cancer	4.79e-05	0.000582	CcSEcCtD
Trifluoperazine—Mequitazine—CYP2D6—breast cancer	4.78e-05	0.0259	CrCbGaD
Trifluoperazine—Muscular weakness—Epirubicin—breast cancer	4.77e-05	0.00058	CcSEcCtD
Trifluoperazine—Alimemazine—CYP3A4—breast cancer	4.77e-05	0.0258	CrCbGaD
Trifluoperazine—Cardiac arrest—Doxorubicin—breast cancer	4.76e-05	0.000579	CcSEcCtD
Trifluoperazine—Constipation—Gemcitabine—breast cancer	4.75e-05	0.000577	CcSEcCtD
Trifluoperazine—Decreased appetite—Fluorouracil—breast cancer	4.75e-05	0.000577	CcSEcCtD
Trifluoperazine—Pancytopenia—Methotrexate—breast cancer	4.75e-05	0.000577	CcSEcCtD
Trifluoperazine—Dry mouth—Paclitaxel—breast cancer	4.75e-05	0.000577	CcSEcCtD
Trifluoperazine—Asthenia—Thiotepa—breast cancer	4.74e-05	0.000576	CcSEcCtD
Trifluoperazine—Nausea—Melphalan—breast cancer	4.7e-05	0.000571	CcSEcCtD
Trifluoperazine—Erythema—Capecitabine—breast cancer	4.68e-05	0.000568	CcSEcCtD
Trifluoperazine—Asthma—Epirubicin—breast cancer	4.68e-05	0.000568	CcSEcCtD
Trifluoperazine—Dysphagia—Epirubicin—breast cancer	4.68e-05	0.000568	CcSEcCtD
Trifluoperazine—Pruritus—Thiotepa—breast cancer	4.67e-05	0.000568	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Paclitaxel—breast cancer	4.65e-05	0.000565	CcSEcCtD
Trifluoperazine—Muscle spasms—Docetaxel—breast cancer	4.65e-05	0.000565	CcSEcCtD
Trifluoperazine—Eosinophilia—Epirubicin—breast cancer	4.63e-05	0.000563	CcSEcCtD
Trifluoperazine—Erectile dysfunction—Methotrexate—breast cancer	4.6e-05	0.000559	CcSEcCtD
Trifluoperazine—Nausea—Goserelin—breast cancer	4.59e-05	0.000557	CcSEcCtD
Trifluoperazine—Dizziness—Vinorelbine—breast cancer	4.57e-05	0.000556	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Methotrexate—breast cancer	4.56e-05	0.000554	CcSEcCtD
Trifluoperazine—Urticaria—Mitoxantrone—breast cancer	4.53e-05	0.000551	CcSEcCtD
Trifluoperazine—Skin disorder—Paclitaxel—breast cancer	4.52e-05	0.000549	CcSEcCtD
Trifluoperazine—Body temperature increased—Mitoxantrone—breast cancer	4.51e-05	0.000548	CcSEcCtD
Trifluoperazine—Body temperature increased—Irinotecan—breast cancer	4.51e-05	0.000548	CcSEcCtD
Trifluoperazine—Muscle spasms—Capecitabine—breast cancer	4.5e-05	0.000547	CcSEcCtD
Trifluoperazine—Drowsiness—Methotrexate—breast cancer	4.46e-05	0.000542	CcSEcCtD
Trifluoperazine—Pancytopenia—Epirubicin—breast cancer	4.44e-05	0.00054	CcSEcCtD
Trifluoperazine—Anorexia—Paclitaxel—breast cancer	4.43e-05	0.000539	CcSEcCtD
Trifluoperazine—Muscular weakness—Doxorubicin—breast cancer	4.42e-05	0.000537	CcSEcCtD
Trifluoperazine—Vision blurred—Capecitabine—breast cancer	4.41e-05	0.000536	CcSEcCtD
Trifluoperazine—Body temperature increased—Gemcitabine—breast cancer	4.39e-05	0.000534	CcSEcCtD
Trifluoperazine—Tremor—Capecitabine—breast cancer	4.38e-05	0.000533	CcSEcCtD
Trifluoperazine—Dizziness—Thiotepa—breast cancer	4.37e-05	0.000531	CcSEcCtD
Trifluoperazine—Rash—Vinorelbine—breast cancer	4.36e-05	0.00053	CcSEcCtD
Trifluoperazine—Dermatitis—Vinorelbine—breast cancer	4.36e-05	0.000529	CcSEcCtD
Trifluoperazine—Hypotension—Paclitaxel—breast cancer	4.35e-05	0.000528	CcSEcCtD
Trifluoperazine—Urticaria—Fluorouracil—breast cancer	4.34e-05	0.000527	CcSEcCtD
Trifluoperazine—Headache—Vinorelbine—breast cancer	4.33e-05	0.000527	CcSEcCtD
Trifluoperazine—Dysphagia—Doxorubicin—breast cancer	4.33e-05	0.000526	CcSEcCtD
Trifluoperazine—Asthma—Doxorubicin—breast cancer	4.33e-05	0.000526	CcSEcCtD
Trifluoperazine—Leukopenia—Docetaxel—breast cancer	4.32e-05	0.000526	CcSEcCtD
Trifluoperazine—Body temperature increased—Fluorouracil—breast cancer	4.32e-05	0.000525	CcSEcCtD
Trifluoperazine—Eosinophilia—Doxorubicin—breast cancer	4.28e-05	0.000521	CcSEcCtD
Trifluoperazine—ABCB1—lymph node—breast cancer	4.28e-05	0.00106	CbGeAlD
Trifluoperazine—Photosensitivity reaction—Epirubicin—breast cancer	4.27e-05	0.000519	CcSEcCtD
Trifluoperazine—Weight increased—Epirubicin—breast cancer	4.26e-05	0.000517	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Epirubicin—breast cancer	4.22e-05	0.000513	CcSEcCtD
Trifluoperazine—Cough—Docetaxel—breast cancer	4.22e-05	0.000512	CcSEcCtD
Trifluoperazine—Insomnia—Paclitaxel—breast cancer	4.21e-05	0.000511	CcSEcCtD
Trifluoperazine—Hypersensitivity—Irinotecan—breast cancer	4.2e-05	0.000511	CcSEcCtD
Trifluoperazine—Hypersensitivity—Mitoxantrone—breast cancer	4.2e-05	0.000511	CcSEcCtD
Trifluoperazine—Leukopenia—Capecitabine—breast cancer	4.19e-05	0.000509	CcSEcCtD
Trifluoperazine—Convulsion—Docetaxel—breast cancer	4.19e-05	0.000509	CcSEcCtD
Trifluoperazine—Drowsiness—Epirubicin—breast cancer	4.17e-05	0.000507	CcSEcCtD
Trifluoperazine—Rash—Thiotepa—breast cancer	4.16e-05	0.000506	CcSEcCtD
Trifluoperazine—Dermatitis—Thiotepa—breast cancer	4.16e-05	0.000506	CcSEcCtD
Trifluoperazine—Agranulocytosis—Methotrexate—breast cancer	4.16e-05	0.000505	CcSEcCtD
Trifluoperazine—Dyspnoea—Paclitaxel—breast cancer	4.15e-05	0.000504	CcSEcCtD
Trifluoperazine—Headache—Thiotepa—breast cancer	4.14e-05	0.000503	CcSEcCtD
Trifluoperazine—Somnolence—Paclitaxel—breast cancer	4.14e-05	0.000503	CcSEcCtD
Trifluoperazine—Pancytopenia—Doxorubicin—breast cancer	4.11e-05	0.000499	CcSEcCtD
Trifluoperazine—Nausea—Vinorelbine—breast cancer	4.11e-05	0.000499	CcSEcCtD
Trifluoperazine—Mequitazine—CYP3A4—breast cancer	4.1e-05	0.0222	CrCbGaD
Trifluoperazine—Asthenia—Irinotecan—breast cancer	4.09e-05	0.000497	CcSEcCtD
Trifluoperazine—Asthenia—Mitoxantrone—breast cancer	4.09e-05	0.000497	CcSEcCtD
Trifluoperazine—Cough—Capecitabine—breast cancer	4.08e-05	0.000496	CcSEcCtD
Trifluoperazine—Jaundice—Epirubicin—breast cancer	4.06e-05	0.000494	CcSEcCtD
Trifluoperazine—Decreased appetite—Paclitaxel—breast cancer	4.04e-05	0.000491	CcSEcCtD
Trifluoperazine—Hypersensitivity—Fluorouracil—breast cancer	4.03e-05	0.000489	CcSEcCtD
Trifluoperazine—Dry mouth—Docetaxel—breast cancer	4.02e-05	0.000489	CcSEcCtD
Trifluoperazine—Fatigue—Paclitaxel—breast cancer	4.01e-05	0.000487	CcSEcCtD
Trifluoperazine—Asthenia—Gemcitabine—breast cancer	3.99e-05	0.000484	CcSEcCtD
Trifluoperazine—Constipation—Paclitaxel—breast cancer	3.98e-05	0.000483	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Doxorubicin—breast cancer	3.95e-05	0.00048	CcSEcCtD
Trifluoperazine—Zuclopenthixol—CYP2D6—breast cancer	3.95e-05	0.0214	CrCbGaD
Trifluoperazine—Anaphylactic shock—Docetaxel—breast cancer	3.94e-05	0.000479	CcSEcCtD
Trifluoperazine—Weight increased—Doxorubicin—breast cancer	3.94e-05	0.000479	CcSEcCtD
Trifluoperazine—Pruritus—Gemcitabine—breast cancer	3.93e-05	0.000478	CcSEcCtD
Trifluoperazine—Nausea—Thiotepa—breast cancer	3.92e-05	0.000477	CcSEcCtD
Trifluoperazine—Nefazodone—CYP2D6—breast cancer	3.92e-05	0.0213	CrCbGaD
Trifluoperazine—Hyperglycaemia—Doxorubicin—breast cancer	3.9e-05	0.000474	CcSEcCtD
Trifluoperazine—Dry mouth—Capecitabine—breast cancer	3.89e-05	0.000473	CcSEcCtD
Trifluoperazine—Agranulocytosis—Epirubicin—breast cancer	3.89e-05	0.000473	CcSEcCtD
Trifluoperazine—Pruritus—Fluorouracil—breast cancer	3.87e-05	0.00047	CcSEcCtD
Trifluoperazine—Drowsiness—Doxorubicin—breast cancer	3.86e-05	0.000469	CcSEcCtD
Trifluoperazine—Skin disorder—Docetaxel—breast cancer	3.83e-05	0.000465	CcSEcCtD
Trifluoperazine—Dizziness—Irinotecan—breast cancer	3.77e-05	0.000458	CcSEcCtD
Trifluoperazine—Jaundice—Doxorubicin—breast cancer	3.76e-05	0.000457	CcSEcCtD
Trifluoperazine—Anorexia—Docetaxel—breast cancer	3.76e-05	0.000457	CcSEcCtD
Trifluoperazine—Skin disorder—Capecitabine—breast cancer	3.71e-05	0.000451	CcSEcCtD
Trifluoperazine—Urticaria—Paclitaxel—breast cancer	3.7e-05	0.000449	CcSEcCtD
Trifluoperazine—Oedema peripheral—Epirubicin—breast cancer	3.69e-05	0.000448	CcSEcCtD
Trifluoperazine—Hypotension—Docetaxel—breast cancer	3.68e-05	0.000448	CcSEcCtD
Trifluoperazine—Body temperature increased—Paclitaxel—breast cancer	3.68e-05	0.000447	CcSEcCtD
Trifluoperazine—Anorexia—Capecitabine—breast cancer	3.64e-05	0.000442	CcSEcCtD
Trifluoperazine—Trazodone—CYP2D6—breast cancer	3.63e-05	0.0197	CrCbGaD
Trifluoperazine—Dizziness—Fluorouracil—breast cancer	3.61e-05	0.000439	CcSEcCtD
Trifluoperazine—Agranulocytosis—Doxorubicin—breast cancer	3.6e-05	0.000438	CcSEcCtD
Trifluoperazine—Rash—Mitoxantrone—breast cancer	3.6e-05	0.000437	CcSEcCtD
Trifluoperazine—Rash—Irinotecan—breast cancer	3.6e-05	0.000437	CcSEcCtD
Trifluoperazine—Dermatitis—Irinotecan—breast cancer	3.59e-05	0.000437	CcSEcCtD
Trifluoperazine—Dermatitis—Mitoxantrone—breast cancer	3.59e-05	0.000437	CcSEcCtD
Trifluoperazine—Headache—Mitoxantrone—breast cancer	3.57e-05	0.000434	CcSEcCtD
Trifluoperazine—Headache—Irinotecan—breast cancer	3.57e-05	0.000434	CcSEcCtD
Trifluoperazine—Hypotension—Capecitabine—breast cancer	3.57e-05	0.000434	CcSEcCtD
Trifluoperazine—Insomnia—Docetaxel—breast cancer	3.57e-05	0.000433	CcSEcCtD
Trifluoperazine—Dyspnoea—Docetaxel—breast cancer	3.52e-05	0.000427	CcSEcCtD
Trifluoperazine—Somnolence—Docetaxel—breast cancer	3.51e-05	0.000426	CcSEcCtD
Trifluoperazine—Rash—Gemcitabine—breast cancer	3.5e-05	0.000426	CcSEcCtD
Trifluoperazine—Dermatitis—Gemcitabine—breast cancer	3.5e-05	0.000425	CcSEcCtD
Trifluoperazine—Erythema—Methotrexate—breast cancer	3.48e-05	0.000423	CcSEcCtD
Trifluoperazine—Headache—Gemcitabine—breast cancer	3.48e-05	0.000423	CcSEcCtD
Trifluoperazine—Insomnia—Capecitabine—breast cancer	3.45e-05	0.00042	CcSEcCtD
Trifluoperazine—Rash—Fluorouracil—breast cancer	3.44e-05	0.000419	CcSEcCtD
Trifluoperazine—Dermatitis—Fluorouracil—breast cancer	3.44e-05	0.000418	CcSEcCtD
Trifluoperazine—Decreased appetite—Docetaxel—breast cancer	3.43e-05	0.000417	CcSEcCtD
Trifluoperazine—Hypersensitivity—Paclitaxel—breast cancer	3.43e-05	0.000417	CcSEcCtD
Trifluoperazine—Headache—Fluorouracil—breast cancer	3.42e-05	0.000416	CcSEcCtD
Trifluoperazine—Oedema peripheral—Doxorubicin—breast cancer	3.41e-05	0.000415	CcSEcCtD
Trifluoperazine—Dyspnoea—Capecitabine—breast cancer	3.4e-05	0.000414	CcSEcCtD
Trifluoperazine—Thiothixene—CYP2D6—breast cancer	3.4e-05	0.0184	CrCbGaD
Trifluoperazine—Pipotiazine—CYP2D6—breast cancer	3.4e-05	0.0184	CrCbGaD
Trifluoperazine—Fatigue—Docetaxel—breast cancer	3.4e-05	0.000413	CcSEcCtD
Trifluoperazine—Nausea—Irinotecan—breast cancer	3.39e-05	0.000412	CcSEcCtD
Trifluoperazine—Nausea—Mitoxantrone—breast cancer	3.39e-05	0.000412	CcSEcCtD
Trifluoperazine—Constipation—Docetaxel—breast cancer	3.37e-05	0.00041	CcSEcCtD
Trifluoperazine—Nefazodone—CYP3A4—breast cancer	3.37e-05	0.0182	CrCbGaD
Trifluoperazine—Chlorpromazine—BCHE—breast cancer	3.36e-05	0.0182	CrCbGaD
Trifluoperazine—Mesoridazine—CYP2D6—breast cancer	3.36e-05	0.0182	CrCbGaD
Trifluoperazine—Asthenia—Paclitaxel—breast cancer	3.34e-05	0.000406	CcSEcCtD
Trifluoperazine—Decreased appetite—Capecitabine—breast cancer	3.32e-05	0.000403	CcSEcCtD
Trifluoperazine—Nausea—Gemcitabine—breast cancer	3.3e-05	0.000401	CcSEcCtD
Trifluoperazine—Fatigue—Capecitabine—breast cancer	3.29e-05	0.0004	CcSEcCtD
Trifluoperazine—Pruritus—Paclitaxel—breast cancer	3.29e-05	0.0004	CcSEcCtD
Trifluoperazine—Vision blurred—Methotrexate—breast cancer	3.28e-05	0.000399	CcSEcCtD
Trifluoperazine—Constipation—Capecitabine—breast cancer	3.26e-05	0.000397	CcSEcCtD
Trifluoperazine—Erythema—Epirubicin—breast cancer	3.26e-05	0.000396	CcSEcCtD
Trifluoperazine—Prochlorperazine—CYP2D6—breast cancer	3.25e-05	0.0176	CrCbGaD
Trifluoperazine—Nausea—Fluorouracil—breast cancer	3.25e-05	0.000394	CcSEcCtD
Trifluoperazine—Nervousness—Epirubicin—breast cancer	3.17e-05	0.000385	CcSEcCtD
Trifluoperazine—Muscle spasms—Epirubicin—breast cancer	3.13e-05	0.000381	CcSEcCtD
Trifluoperazine—Body temperature increased—Docetaxel—breast cancer	3.12e-05	0.000379	CcSEcCtD
Trifluoperazine—Leukopenia—Methotrexate—breast cancer	3.12e-05	0.000379	CcSEcCtD
Trifluoperazine—Trazodone—CYP3A4—breast cancer	3.11e-05	0.0169	CrCbGaD
Trifluoperazine—Dizziness—Paclitaxel—breast cancer	3.08e-05	0.000374	CcSEcCtD
Trifluoperazine—Vision blurred—Epirubicin—breast cancer	3.07e-05	0.000373	CcSEcCtD
Trifluoperazine—Cough—Methotrexate—breast cancer	3.04e-05	0.000369	CcSEcCtD
Trifluoperazine—Urticaria—Capecitabine—breast cancer	3.03e-05	0.000369	CcSEcCtD
Trifluoperazine—Body temperature increased—Capecitabine—breast cancer	3.02e-05	0.000367	CcSEcCtD
Trifluoperazine—Convulsion—Methotrexate—breast cancer	3.02e-05	0.000367	CcSEcCtD
Trifluoperazine—Erythema—Doxorubicin—breast cancer	3.02e-05	0.000366	CcSEcCtD
Trifluoperazine—Agitation—Epirubicin—breast cancer	2.99e-05	0.000364	CcSEcCtD
Trifluoperazine—Fluphenazine—CYP2D6—breast cancer	2.94e-05	0.0159	CrCbGaD
Trifluoperazine—Rash—Paclitaxel—breast cancer	2.93e-05	0.000356	CcSEcCtD
Trifluoperazine—Dermatitis—Paclitaxel—breast cancer	2.93e-05	0.000356	CcSEcCtD
Trifluoperazine—Nervousness—Doxorubicin—breast cancer	2.93e-05	0.000356	CcSEcCtD
Trifluoperazine—Pipotiazine—CYP3A4—breast cancer	2.92e-05	0.0158	CrCbGaD
Trifluoperazine—Leukopenia—Epirubicin—breast cancer	2.92e-05	0.000355	CcSEcCtD
Trifluoperazine—Headache—Paclitaxel—breast cancer	2.91e-05	0.000354	CcSEcCtD
Trifluoperazine—Hypersensitivity—Docetaxel—breast cancer	2.91e-05	0.000353	CcSEcCtD
Trifluoperazine—Muscle spasms—Doxorubicin—breast cancer	2.9e-05	0.000352	CcSEcCtD
Trifluoperazine—Cough—Epirubicin—breast cancer	2.84e-05	0.000346	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Methotrexate—breast cancer	2.84e-05	0.000345	CcSEcCtD
Trifluoperazine—Vision blurred—Doxorubicin—breast cancer	2.84e-05	0.000345	CcSEcCtD
Trifluoperazine—Asthenia—Docetaxel—breast cancer	2.83e-05	0.000344	CcSEcCtD
Trifluoperazine—Convulsion—Epirubicin—breast cancer	2.82e-05	0.000343	CcSEcCtD
Trifluoperazine—Hypersensitivity—Capecitabine—breast cancer	2.81e-05	0.000342	CcSEcCtD
Trifluoperazine—Nefazodone—ABCB1—breast cancer	2.8e-05	0.0152	CrCbGaD
Trifluoperazine—Pruritus—Docetaxel—breast cancer	2.79e-05	0.000339	CcSEcCtD
Trifluoperazine—Prochlorperazine—CYP3A4—breast cancer	2.79e-05	0.0151	CrCbGaD
Trifluoperazine—Agitation—Doxorubicin—breast cancer	2.77e-05	0.000337	CcSEcCtD
Trifluoperazine—Nausea—Paclitaxel—breast cancer	2.76e-05	0.000336	CcSEcCtD
Trifluoperazine—Skin disorder—Methotrexate—breast cancer	2.76e-05	0.000335	CcSEcCtD
Trifluoperazine—Asthenia—Capecitabine—breast cancer	2.74e-05	0.000333	CcSEcCtD
Trifluoperazine—Triflupromazine—ABCB1—breast cancer	2.73e-05	0.0148	CrCbGaD
Trifluoperazine—Dry mouth—Epirubicin—breast cancer	2.71e-05	0.00033	CcSEcCtD
Trifluoperazine—Anorexia—Methotrexate—breast cancer	2.71e-05	0.000329	CcSEcCtD
Trifluoperazine—Pruritus—Capecitabine—breast cancer	2.7e-05	0.000328	CcSEcCtD
Trifluoperazine—Leukopenia—Doxorubicin—breast cancer	2.7e-05	0.000328	CcSEcCtD
Trifluoperazine—Clomipramine—CYP2D6—breast cancer	2.69e-05	0.0146	CrCbGaD
Trifluoperazine—Anaphylactic shock—Epirubicin—breast cancer	2.66e-05	0.000323	CcSEcCtD
Trifluoperazine—Hypotension—Methotrexate—breast cancer	2.66e-05	0.000323	CcSEcCtD
Trifluoperazine—Acepromazine—ALB—breast cancer	2.65e-05	0.0143	CrCbGaD
Trifluoperazine—Clozapine—CYP1A1—breast cancer	2.63e-05	0.0143	CrCbGaD
Trifluoperazine—Cough—Doxorubicin—breast cancer	2.63e-05	0.00032	CcSEcCtD
Trifluoperazine—Convulsion—Doxorubicin—breast cancer	2.61e-05	0.000317	CcSEcCtD
Trifluoperazine—Dizziness—Docetaxel—breast cancer	2.61e-05	0.000317	CcSEcCtD
Trifluoperazine—Trazodone—ABCB1—breast cancer	2.59e-05	0.0141	CrCbGaD
Trifluoperazine—Thioproperazine—ALB—breast cancer	2.59e-05	0.014	CrCbGaD
Trifluoperazine—Skin disorder—Epirubicin—breast cancer	2.58e-05	0.000314	CcSEcCtD
Trifluoperazine—Insomnia—Methotrexate—breast cancer	2.57e-05	0.000312	CcSEcCtD
Trifluoperazine—Pipotiazine—ALB—breast cancer	2.55e-05	0.0138	CrCbGaD
Trifluoperazine—Thiothixene—ALB—breast cancer	2.55e-05	0.0138	CrCbGaD
Trifluoperazine—Anorexia—Epirubicin—breast cancer	2.54e-05	0.000308	CcSEcCtD
Trifluoperazine—Dyspnoea—Methotrexate—breast cancer	2.53e-05	0.000308	CcSEcCtD
Trifluoperazine—Thioridazine—CYP2D6—breast cancer	2.53e-05	0.0137	CrCbGaD
Trifluoperazine—Somnolence—Methotrexate—breast cancer	2.53e-05	0.000307	CcSEcCtD
Trifluoperazine—Dizziness—Capecitabine—breast cancer	2.52e-05	0.000307	CcSEcCtD
Trifluoperazine—Dry mouth—Doxorubicin—breast cancer	2.51e-05	0.000305	CcSEcCtD
Trifluoperazine—Rash—Docetaxel—breast cancer	2.49e-05	0.000302	CcSEcCtD
Trifluoperazine—Hypotension—Epirubicin—breast cancer	2.49e-05	0.000302	CcSEcCtD
Trifluoperazine—Dermatitis—Docetaxel—breast cancer	2.48e-05	0.000302	CcSEcCtD
Trifluoperazine—Decreased appetite—Methotrexate—breast cancer	2.47e-05	0.0003	CcSEcCtD
Trifluoperazine—Headache—Docetaxel—breast cancer	2.47e-05	0.0003	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Doxorubicin—breast cancer	2.46e-05	0.000299	CcSEcCtD
Trifluoperazine—Fatigue—Methotrexate—breast cancer	2.45e-05	0.000298	CcSEcCtD
Trifluoperazine—Methotrimeprazine—CYP2D6—breast cancer	2.42e-05	0.0131	CrCbGaD
Trifluoperazine—Rash—Capecitabine—breast cancer	2.41e-05	0.000293	CcSEcCtD
Trifluoperazine—Insomnia—Epirubicin—breast cancer	2.41e-05	0.000292	CcSEcCtD
Trifluoperazine—Dermatitis—Capecitabine—breast cancer	2.4e-05	0.000292	CcSEcCtD
Trifluoperazine—Headache—Capecitabine—breast cancer	2.39e-05	0.000291	CcSEcCtD
Trifluoperazine—Skin disorder—Doxorubicin—breast cancer	2.39e-05	0.00029	CcSEcCtD
Trifluoperazine—Promethazine—CYP2D6—breast cancer	2.38e-05	0.0129	CrCbGaD
Trifluoperazine—Dyspnoea—Epirubicin—breast cancer	2.37e-05	0.000288	CcSEcCtD
Trifluoperazine—Somnolence—Epirubicin—breast cancer	2.36e-05	0.000287	CcSEcCtD
Trifluoperazine—Anorexia—Doxorubicin—breast cancer	2.35e-05	0.000285	CcSEcCtD
Trifluoperazine—Nausea—Docetaxel—breast cancer	2.34e-05	0.000285	CcSEcCtD
Trifluoperazine—Perphenazine—CYP2D6—breast cancer	2.32e-05	0.0126	CrCbGaD
Trifluoperazine—Decreased appetite—Epirubicin—breast cancer	2.31e-05	0.000281	CcSEcCtD
Trifluoperazine—Clomipramine—CYP3A4—breast cancer	2.31e-05	0.0125	CrCbGaD
Trifluoperazine—Hypotension—Doxorubicin—breast cancer	2.3e-05	0.000279	CcSEcCtD
Trifluoperazine—Fatigue—Epirubicin—breast cancer	2.29e-05	0.000279	CcSEcCtD
Trifluoperazine—Quetiapine—CYP2D6—breast cancer	2.28e-05	0.0124	CrCbGaD
Trifluoperazine—Constipation—Epirubicin—breast cancer	2.27e-05	0.000276	CcSEcCtD
Trifluoperazine—Nausea—Capecitabine—breast cancer	2.27e-05	0.000276	CcSEcCtD
Trifluoperazine—Urticaria—Methotrexate—breast cancer	2.26e-05	0.000274	CcSEcCtD
Trifluoperazine—Body temperature increased—Methotrexate—breast cancer	2.25e-05	0.000273	CcSEcCtD
Trifluoperazine—Insomnia—Doxorubicin—breast cancer	2.23e-05	0.00027	CcSEcCtD
Trifluoperazine—Dyspnoea—Doxorubicin—breast cancer	2.19e-05	0.000267	CcSEcCtD
Trifluoperazine—Somnolence—Doxorubicin—breast cancer	2.19e-05	0.000266	CcSEcCtD
Trifluoperazine—Decreased appetite—Doxorubicin—breast cancer	2.14e-05	0.00026	CcSEcCtD
Trifluoperazine—Fatigue—Doxorubicin—breast cancer	2.12e-05	0.000258	CcSEcCtD
Trifluoperazine—Urticaria—Epirubicin—breast cancer	2.11e-05	0.000257	CcSEcCtD
Trifluoperazine—Constipation—Doxorubicin—breast cancer	2.1e-05	0.000256	CcSEcCtD
Trifluoperazine—Body temperature increased—Epirubicin—breast cancer	2.1e-05	0.000256	CcSEcCtD
Trifluoperazine—Fluphenazine—ABCB1—breast cancer	2.1e-05	0.0114	CrCbGaD
Trifluoperazine—Hypersensitivity—Methotrexate—breast cancer	2.09e-05	0.000254	CcSEcCtD
Trifluoperazine—Asthenia—Methotrexate—breast cancer	2.04e-05	0.000248	CcSEcCtD
Trifluoperazine—Clomipramine—ALB—breast cancer	2.01e-05	0.0109	CrCbGaD
Trifluoperazine—Pruritus—Methotrexate—breast cancer	2.01e-05	0.000244	CcSEcCtD
Trifluoperazine—Perphenazine—CYP3A4—breast cancer	1.99e-05	0.0108	CrCbGaD
Trifluoperazine—Clozapine—CYP2D6—breast cancer	1.96e-05	0.0106	CrCbGaD
Trifluoperazine—Hypersensitivity—Epirubicin—breast cancer	1.96e-05	0.000238	CcSEcCtD
Trifluoperazine—Quetiapine—CYP3A4—breast cancer	1.96e-05	0.0106	CrCbGaD
Trifluoperazine—Urticaria—Doxorubicin—breast cancer	1.96e-05	0.000238	CcSEcCtD
Trifluoperazine—Body temperature increased—Doxorubicin—breast cancer	1.95e-05	0.000236	CcSEcCtD
Trifluoperazine—Clomipramine—ABCB1—breast cancer	1.92e-05	0.0104	CrCbGaD
Trifluoperazine—Asthenia—Epirubicin—breast cancer	1.91e-05	0.000232	CcSEcCtD
Trifluoperazine—Pruritus—Epirubicin—breast cancer	1.88e-05	0.000229	CcSEcCtD
Trifluoperazine—Dizziness—Methotrexate—breast cancer	1.88e-05	0.000228	CcSEcCtD
Trifluoperazine—Chlorpromazine—CYP2D6—breast cancer	1.84e-05	0.01	CrCbGaD
Trifluoperazine—Hypersensitivity—Doxorubicin—breast cancer	1.81e-05	0.00022	CcSEcCtD
Trifluoperazine—Promazine—CYP3A4—breast cancer	1.8e-05	0.00974	CrCbGaD
Trifluoperazine—Rash—Methotrexate—breast cancer	1.79e-05	0.000218	CcSEcCtD
Trifluoperazine—Dermatitis—Methotrexate—breast cancer	1.79e-05	0.000218	CcSEcCtD
Trifluoperazine—Headache—Methotrexate—breast cancer	1.78e-05	0.000216	CcSEcCtD
Trifluoperazine—Asthenia—Doxorubicin—breast cancer	1.77e-05	0.000215	CcSEcCtD
Trifluoperazine—Dizziness—Epirubicin—breast cancer	1.76e-05	0.000214	CcSEcCtD
Trifluoperazine—Pruritus—Doxorubicin—breast cancer	1.74e-05	0.000212	CcSEcCtD
Trifluoperazine—Promethazine—ABCB1—breast cancer	1.7e-05	0.00922	CrCbGaD
Trifluoperazine—Nausea—Methotrexate—breast cancer	1.69e-05	0.000205	CcSEcCtD
Trifluoperazine—Clozapine—CYP3A4—breast cancer	1.68e-05	0.00912	CrCbGaD
Trifluoperazine—Rash—Epirubicin—breast cancer	1.68e-05	0.000204	CcSEcCtD
Trifluoperazine—Dermatitis—Epirubicin—breast cancer	1.68e-05	0.000204	CcSEcCtD
Trifluoperazine—Headache—Epirubicin—breast cancer	1.67e-05	0.000202	CcSEcCtD
Trifluoperazine—Quetiapine—ABCB1—breast cancer	1.63e-05	0.00882	CrCbGaD
Trifluoperazine—Dizziness—Doxorubicin—breast cancer	1.63e-05	0.000198	CcSEcCtD
Trifluoperazine—Chlorpromazine—CYP3A4—breast cancer	1.58e-05	0.00858	CrCbGaD
Trifluoperazine—Nausea—Epirubicin—breast cancer	1.58e-05	0.000192	CcSEcCtD
Trifluoperazine—Rash—Doxorubicin—breast cancer	1.55e-05	0.000189	CcSEcCtD
Trifluoperazine—Dermatitis—Doxorubicin—breast cancer	1.55e-05	0.000188	CcSEcCtD
Trifluoperazine—Headache—Doxorubicin—breast cancer	1.54e-05	0.000187	CcSEcCtD
Trifluoperazine—Nausea—Doxorubicin—breast cancer	1.46e-05	0.000178	CcSEcCtD
Trifluoperazine—Clozapine—ABCB1—breast cancer	1.4e-05	0.00759	CrCbGaD
Trifluoperazine—Chlorpromazine—ALB—breast cancer	1.38e-05	0.00748	CrCbGaD
Trifluoperazine—Chlorpromazine—ABCB1—breast cancer	1.32e-05	0.00714	CrCbGaD
Trifluoperazine—HTR6—Signaling Pathways—IL6—breast cancer	6.87e-07	8.62e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MAPK8—breast cancer	6.87e-07	8.61e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—AKT1—breast cancer	6.86e-07	8.61e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—AKT1—breast cancer	6.85e-07	8.59e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—ERBB2—breast cancer	6.85e-07	8.59e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—EGFR—breast cancer	6.78e-07	8.5e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MYC—breast cancer	6.77e-07	8.49e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PIK3CB—breast cancer	6.76e-07	8.48e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MTOR—breast cancer	6.76e-07	8.48e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MAPK8—breast cancer	6.76e-07	8.48e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PTEN—breast cancer	6.76e-07	8.47e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PTEN—breast cancer	6.76e-07	8.47e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TGFB1—breast cancer	6.75e-07	8.47e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—PIK3CA—breast cancer	6.75e-07	8.46e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—PIK3CA—breast cancer	6.75e-07	8.46e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—AKT1—breast cancer	6.74e-07	8.45e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MAPK8—breast cancer	6.74e-07	8.45e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MYC—breast cancer	6.73e-07	8.45e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—AKT1—breast cancer	6.72e-07	8.43e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MDM2—breast cancer	6.72e-07	8.43e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MDM2—breast cancer	6.72e-07	8.43e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TGFB1—breast cancer	6.72e-07	8.42e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—KRAS—breast cancer	6.71e-07	8.42e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—KRAS—breast cancer	6.71e-07	8.42e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—MYC—breast cancer	6.71e-07	8.41e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—MYC—breast cancer	6.71e-07	8.41e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—RAF1—breast cancer	6.7e-07	8.4e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—RAF1—breast cancer	6.7e-07	8.4e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	6.69e-07	8.4e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—TGFB1—breast cancer	6.69e-07	8.39e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—TGFB1—breast cancer	6.69e-07	8.39e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—RELA—breast cancer	6.67e-07	8.36e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—RELA—breast cancer	6.67e-07	8.36e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—NOS3—breast cancer	6.64e-07	8.32e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—SRC—breast cancer	6.63e-07	8.32e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—ERBB2—breast cancer	6.63e-07	8.31e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—ERBB2—breast cancer	6.63e-07	8.31e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—EGFR—breast cancer	6.62e-07	8.3e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—EGFR—breast cancer	6.59e-07	8.26e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—EGFR—breast cancer	6.56e-07	8.23e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—EGFR—breast cancer	6.56e-07	8.23e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MTOR—breast cancer	6.54e-07	8.2e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PIK3CB—breast cancer	6.54e-07	8.2e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MTOR—breast cancer	6.54e-07	8.2e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PIK3CB—breast cancer	6.54e-07	8.2e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—SRC—breast cancer	6.53e-07	8.18e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—SRC—breast cancer	6.51e-07	8.17e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CXCL8—breast cancer	6.5e-07	8.15e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—VEGFA—breast cancer	6.46e-07	8.1e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—HRAS—breast cancer	6.45e-07	8.09e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—SRC—breast cancer	6.41e-07	8.04e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—KRAS—breast cancer	6.4e-07	8.03e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—STAT3—breast cancer	6.4e-07	8.02e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—SRC—breast cancer	6.39e-07	8.01e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CG—breast cancer	6.38e-07	8e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—PIK3CA—breast cancer	6.37e-07	7.99e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—VEGFA—breast cancer	6.36e-07	7.97e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CDKN1B—breast cancer	6.34e-07	7.96e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—VEGFA—breast cancer	6.34e-07	7.95e-06	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—AKT1—breast cancer	6.34e-07	7.95e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—STAT3—breast cancer	6.29e-07	7.89e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CXCL8—breast cancer	6.28e-07	7.88e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CXCL8—breast cancer	6.28e-07	7.88e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—STAT3—breast cancer	6.28e-07	7.88e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—KRAS—breast cancer	6.25e-07	7.84e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—HRAS—breast cancer	6.24e-07	7.83e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—HRAS—breast cancer	6.24e-07	7.83e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—VEGFA—breast cancer	6.24e-07	7.83e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	6.22e-07	7.8e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—KRAS—breast cancer	6.22e-07	7.8e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CASP3—breast cancer	6.22e-07	7.8e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL2—breast cancer	6.21e-07	7.79e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—KRAS—breast cancer	6.2e-07	7.77e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—KRAS—breast cancer	6.2e-07	7.77e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—STAT3—breast cancer	6.18e-07	7.75e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—IL6—breast cancer	6.18e-07	7.75e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—PIK3CA—breast cancer	6.17e-07	7.73e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—PIK3CA—breast cancer	6.17e-07	7.73e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—STAT3—breast cancer	6.16e-07	7.73e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CDKN1B—breast cancer	6.14e-07	7.7e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CDKN1B—breast cancer	6.14e-07	7.7e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PIK3CB—breast cancer	6.13e-07	7.68e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MAPK3—breast cancer	6.11e-07	7.66e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PTGS2—breast cancer	6.07e-07	7.61e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CCND1—breast cancer	6.05e-07	7.59e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—JUN—breast cancer	6.04e-07	7.57e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CASP3—breast cancer	6.01e-07	7.54e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CASP3—breast cancer	6.01e-07	7.54e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MAPK3—breast cancer	6.01e-07	7.54e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL2—breast cancer	6.01e-07	7.53e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL2—breast cancer	6.01e-07	7.53e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MAPK3—breast cancer	6e-07	7.52e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CTNNB1—breast cancer	5.99e-07	7.52e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—IL6—breast cancer	5.98e-07	7.49e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—IL6—breast cancer	5.98e-07	7.49e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MYC—breast cancer	5.94e-07	7.45e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TGFB1—breast cancer	5.93e-07	7.44e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MAPK3—breast cancer	5.9e-07	7.4e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—HRAS—breast cancer	5.9e-07	7.4e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	5.89e-07	7.38e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—PIK3CA—breast cancer	5.88e-07	7.38e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MMP9—breast cancer	5.88e-07	7.37e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CDKN1A—breast cancer	5.85e-07	7.34e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CCND1—breast cancer	5.85e-07	7.34e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCND1—breast cancer	5.85e-07	7.34e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MYC—breast cancer	5.85e-07	7.33e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—JUN—breast cancer	5.84e-07	7.33e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—JUN—breast cancer	5.84e-07	7.33e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PTEN—breast cancer	5.84e-07	7.33e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MYC—breast cancer	5.83e-07	7.32e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TGFB1—breast cancer	5.83e-07	7.32e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TGFB1—breast cancer	5.82e-07	7.3e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—EGFR—breast cancer	5.81e-07	7.29e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CTNNB1—breast cancer	5.8e-07	7.27e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CTNNB1—breast cancer	5.8e-07	7.27e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—PIK3CA—breast cancer	5.75e-07	7.21e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MYC—breast cancer	5.74e-07	7.2e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TGFB1—breast cancer	5.73e-07	7.18e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MYC—breast cancer	5.73e-07	7.18e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—EGFR—breast cancer	5.72e-07	7.17e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—PIK3CA—breast cancer	5.72e-07	7.17e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MAPK8—breast cancer	5.71e-07	7.17e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	5.71e-07	7.16e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—EGFR—breast cancer	5.71e-07	7.16e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—HRAS—breast cancer	5.7e-07	7.15e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—HRAS—breast cancer	5.7e-07	7.15e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—AKT1—breast cancer	5.7e-07	7.15e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—PIK3CA—breast cancer	5.69e-07	7.14e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—PIK3CA—breast cancer	5.69e-07	7.14e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MMP9—breast cancer	5.68e-07	7.13e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MMP9—breast cancer	5.68e-07	7.13e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CDKN1A—breast cancer	5.66e-07	7.1e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CDKN1A—breast cancer	5.66e-07	7.1e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PTEN—breast cancer	5.65e-07	7.09e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PTEN—breast cancer	5.65e-07	7.09e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL6—breast cancer	5.64e-07	7.08e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—EGFR—breast cancer	5.62e-07	7.04e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CD—breast cancer	5.61e-07	7.04e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—EGFR—breast cancer	5.6e-07	7.02e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TP53—breast cancer	5.56e-07	6.97e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—ALB—breast cancer	5.54e-07	6.95e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TP53—breast cancer	5.53e-07	6.94e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MAPK8—breast cancer	5.53e-07	6.93e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MAPK8—breast cancer	5.53e-07	6.93e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—AKT1—breast cancer	5.51e-07	6.91e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—AKT1—breast cancer	5.51e-07	6.91e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—KRAS—breast cancer	5.49e-07	6.89e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL6—breast cancer	5.46e-07	6.85e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL6—breast cancer	5.46e-07	6.85e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—HRAS—breast cancer	5.44e-07	6.83e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—SRC—breast cancer	5.42e-07	6.79e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—KRAS—breast cancer	5.4e-07	6.78e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—KRAS—breast cancer	5.39e-07	6.76e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—HRAS—breast cancer	5.32e-07	6.67e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—KRAS—breast cancer	5.3e-07	6.65e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—NOS3—breast cancer	5.3e-07	6.65e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PTEN—breast cancer	5.29e-07	6.64e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—KRAS—breast cancer	5.29e-07	6.64e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—HRAS—breast cancer	5.29e-07	6.63e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—VEGFA—breast cancer	5.28e-07	6.62e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—HRAS—breast cancer	5.27e-07	6.6e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—HRAS—breast cancer	5.27e-07	6.6e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—SRC—breast cancer	5.24e-07	6.57e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—SRC—breast cancer	5.24e-07	6.57e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—STAT3—breast cancer	5.22e-07	6.55e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—IL6—breast cancer	5.21e-07	6.53e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—AKT1—breast cancer	5.21e-07	6.53e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—VEGFA—breast cancer	5.1e-07	6.4e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—VEGFA—breast cancer	5.1e-07	6.4e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IL6—breast cancer	5.09e-07	6.38e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IL6—breast cancer	5.06e-07	6.35e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—STAT3—breast cancer	5.05e-07	6.34e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—STAT3—breast cancer	5.05e-07	6.34e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—PIK3CA—breast cancer	5.04e-07	6.33e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—IL6—breast cancer	5.04e-07	6.32e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—IL6—breast cancer	5.04e-07	6.32e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—AKT1—breast cancer	5.04e-07	6.32e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—AKT1—breast cancer	5.04e-07	6.32e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MAPK3—breast cancer	4.99e-07	6.26e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—PIK3CA—breast cancer	4.96e-07	6.23e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—PIK3CA—breast cancer	4.95e-07	6.21e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PIK3CA—breast cancer	4.93e-07	6.18e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CB—breast cancer	4.89e-07	6.13e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TP53—breast cancer	4.88e-07	6.12e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—PIK3CA—breast cancer	4.87e-07	6.11e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	4.86e-07	6.1e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MYC—breast cancer	4.85e-07	6.09e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PTGS2—breast cancer	4.85e-07	6.08e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TGFB1—breast cancer	4.84e-07	6.07e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MAPK3—breast cancer	4.83e-07	6.05e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MAPK3—breast cancer	4.83e-07	6.05e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—AKT1—breast cancer	4.81e-07	6.03e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TP53—breast cancer	4.8e-07	6.02e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TP53—breast cancer	4.79e-07	6.01e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PIK3CA—breast cancer	4.77e-07	5.98e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PIK3CA—breast cancer	4.77e-07	5.98e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—EGFR—breast cancer	4.75e-07	5.95e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TP53—breast cancer	4.71e-07	5.91e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TP53—breast cancer	4.7e-07	5.9e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MYC—breast cancer	4.7e-07	5.89e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MYC—breast cancer	4.7e-07	5.89e-06	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—AKT1—breast cancer	4.69e-07	5.89e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TGFB1—breast cancer	4.68e-07	5.87e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TGFB1—breast cancer	4.68e-07	5.87e-06	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—AKT1—breast cancer	4.67e-07	5.86e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—HRAS—breast cancer	4.67e-07	5.85e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—AKT1—breast cancer	4.65e-07	5.83e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—AKT1—breast cancer	4.65e-07	5.83e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—EGFR—breast cancer	4.59e-07	5.76e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—EGFR—breast cancer	4.59e-07	5.76e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—HRAS—breast cancer	4.59e-07	5.76e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—HRAS—breast cancer	4.58e-07	5.75e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—HRAS—breast cancer	4.51e-07	5.66e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—HRAS—breast cancer	4.5e-07	5.64e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—KRAS—breast cancer	4.49e-07	5.63e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IL6—breast cancer	4.47e-07	5.6e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL6—breast cancer	4.4e-07	5.51e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL6—breast cancer	4.39e-07	5.5e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—KRAS—breast cancer	4.34e-07	5.44e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—KRAS—breast cancer	4.34e-07	5.44e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL6—breast cancer	4.32e-07	5.41e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL6—breast cancer	4.3e-07	5.4e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PTEN—breast cancer	4.23e-07	5.3e-06	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—AKT1—breast cancer	4.12e-07	5.17e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PIK3CA—breast cancer	4.12e-07	5.17e-06	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—AKT1—breast cancer	4.06e-07	5.09e-06	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—AKT1—breast cancer	4.05e-07	5.07e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—AKT1—breast cancer	4.03e-07	5.05e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TP53—breast cancer	3.99e-07	5e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PIK3CA—breast cancer	3.99e-07	5e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PIK3CA—breast cancer	3.99e-07	5e-06	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—AKT1—breast cancer	3.98e-07	4.99e-06	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—AKT1—breast cancer	3.97e-07	4.98e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—AKT1—breast cancer	3.89e-07	4.88e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—AKT1—breast cancer	3.89e-07	4.88e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TP53—breast cancer	3.86e-07	4.84e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TP53—breast cancer	3.86e-07	4.84e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—HRAS—breast cancer	3.81e-07	4.78e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PIK3CA—breast cancer	3.73e-07	4.68e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—HRAS—breast cancer	3.69e-07	4.63e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—HRAS—breast cancer	3.69e-07	4.63e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL6—breast cancer	3.65e-07	4.58e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL6—breast cancer	3.53e-07	4.43e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL6—breast cancer	3.53e-07	4.43e-06	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—AKT1—breast cancer	3.37e-07	4.22e-06	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—AKT1—breast cancer	3.26e-07	4.08e-06	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—AKT1—breast cancer	3.26e-07	4.08e-06	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—AKT1—breast cancer	3.05e-07	3.83e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CA—breast cancer	2.98e-07	3.74e-06	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—AKT1—breast cancer	2.44e-07	3.05e-06	CbGpPWpGaD
